Hermann Einsele
Expertise in
25
conditions

Hermann Einsele

Internal Medicine
Oberdürrbacher Str. 6, 
Wuerzburg, BY, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
25
conditions
Oberdürrbacher Str. 6, 
Wuerzburg, BY, DE 

Overview

Hermann Einsele is a primary care provider, practicing in Internal Medicine in Wuerzburg, Germany.

Mr. Einsele is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Aspergillosis, Leukemia, and Graft Versus Host Disease (GvHD).

He is actively involved in clinical research, co-authoring 685 peer reviewed articles and participating in 3 clinical trials.

Specialties

Internal Medicine

Gender

Male

Locations

Oberdürrbacher Str. 6, Wuerzburg, BY 97080, Germany
Other Locations
Oberdürrbacher Street 6, Wuerzburg, BY 97080, Germany
Josef Schneider Str. 2, Wuerzburg, BY 97080, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Treatment of Chemo-refractory Viral Infections After Allogeneic Stem Cell Transplantation With Multispecific T Cells Against CMV, EBV and AdV: A Phase III, Prospective, Multicentre Clinical Trial
Treatment of Chemo-refractory Viral Infections After Allogeneic Stem Cell Transplantation With Multispecific T Cells Against CMV, EBV and AdV: A Phase III, Prospective, Multicentre Clinical Trial
Enrollment Status: Recruiting
Publish Date: July 18, 2025
Intervention Type: Other
Study Phase: Phase 3
Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance - A Randomized Multicenter Phase III Trial by Deutsche Studiengruppe Multiples Myelom (DSMM XIV
Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance - A Randomized Multicenter Phase III Trial by Deutsche Studiengruppe Multiples Myelom (DSMM XIV
Enrollment Status: Unknown
Publish Date: April 27, 2023
Intervention Type: Biological, Drug
Study Drugs: Lenalidomide, Bortezomib, Autologous Stem Cell Transplant, Aallogeneic Stem Cell Transplant
Study Phase: Phase 3
Multicenter Phase II Study of Haploidentical Hematopoietic Cell Transplantation With CD3/CD19 Depleted Grafts After a Reduced Intensity Conditioning Regimen for Adult Patients With Acute Leukemia
Multicenter Phase II Study of Haploidentical Hematopoietic Cell Transplantation With CD3/CD19 Depleted Grafts After a Reduced Intensity Conditioning Regimen for Adult Patients With Acute Leukemia
Enrollment Status: Terminated
Publish Date: July 05, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trial

685 Total Publications

Correction: Prospective single-center study of health-related quality of life after COVID-19 in ICU and non-ICU patients.
Correction: Prospective single-center study of health-related quality of life after COVID-19 in ICU and non-ICU patients.
Journal: Scientific reports
Published: August 26, 2026

Frequently Asked Questions about Hermann Einsele

Is Hermann Einsele a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Hermann Einsele is classified as an Elite expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Hermann Einsele specialize in?

While Hermann Einsele is a Internal Medicine, they have specific expertise in Multiple Myeloma, Aspergillosis, and Leukemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Hermann Einsele participate in research or clinical trials?

Yes. Hermann Einsele has published 685 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Hermann Einsele's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Einsele's expertise for a condition
ConditionClose
View All 17 Advanced Conditions
View All 44 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile